about
Medical treatment of early stage and rare histological variants of epithelial ovarian cancerHigh MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival timeMucinous adenocarcinoma involving the ovary: comparative evaluation of the classification algorithms using tumor size and lateralityClinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer.Targeting SRC in mucinous ovarian carcinoma.Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer.Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary.Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancersTargeting signaling pathways in epithelial ovarian cancer.Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer.Mucinous tumours of appendix and ovary: an overview and evaluation of current practice.Republished: mucinous tumours of appendix and ovary: an overview and evaluation of current practice.Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma.The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion.Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
P2860
Q26777702-644C5E8B-628B-4FA1-8990-1CEB987D0D98Q28536347-1DBFA5AB-85BC-4279-8D64-CB43D98A9B97Q33609964-740C7717-2EC7-47F4-AA9B-1762AE3BD72EQ33618894-2CBE7D5B-EC7A-4BC8-A745-71BFC9D8FE01Q33638051-C7DB8F94-7599-4823-9037-0037E1981340Q35076986-F47179BB-AE67-4FAB-A057-36DE155A490DQ35429938-874FBF0C-386C-4807-9FAE-FE179DC86570Q36546449-F3F8505F-4659-478D-B257-8DB59C9F2015Q36913614-F4521570-98AE-4735-B08E-FA8B9663A90CQ37141055-8FF51E21-0315-4042-AAE2-A87582CD53E3Q37301884-4A3B2AD5-F283-4DAF-A2A4-E31331D0D249Q37480057-4D274854-9F65-409E-B8B9-F0B9E83DAA8CQ38080036-F7CAD58D-CAE3-468E-8E17-2E16DE9DE07EQ38165153-11FF9EB8-AB8B-4F3E-B315-E6A9725FCE2CQ38316489-A607C06B-7DC2-4B6D-8369-C8CFA980DDF3Q38382139-BB8C1314-7979-42DC-A6D2-B06A7EE32170Q39118890-DF11BDBE-4623-4BC2-86E9-1CBC08366FFFQ47254055-82C3E4AF-F135-47FC-8843-7760F55B717AQ52643559-FDCCA256-779B-4BB6-A290-1688E074DF7DQ53286591-84A20268-44BF-4537-9632-9C78EDB2B8E5Q58704255-B9332AFD-E28B-4385-A315-358E29DDF981
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mucinous ovarian cancer.
@en
type
label
Mucinous ovarian cancer.
@en
prefLabel
Mucinous ovarian cancer.
@en
P2093
P1476
Mucinous ovarian cancer.
@en
P2093
P304
P356
10.1111/J.1525-1438.2007.01022.X
P577
2007-07-11T00:00:00Z